DP
ITOS

Diadema Partners’s iTeos Therapeutics ITOS Stock Holding History

Diadema Partners’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-206,200
Closed -$2.06M – 145
2025
Q2 		$2.06M Buy
+206,200
New +$1.66M 0.63% 41

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Diadema Partners's ITOS Position: Q3 2025 in Review

Diadema Partners sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 206,200 shares — an estimated $2.06M sold.

Diadema Partners first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $2.06M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Diadema Partners reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Diadema Partners sold 206,200 iTeos Therapeutics shares in Q3 2025, an estimated $2.06M.
  • Diadema Partners first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Diadema Partners's iTeos Therapeutics position peaked at $2.06M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Diadema Partners's 13F filing for Q3 2025, filed 14 Nov 2025.